1.Prevalence of HIV, Hepatitis B and C Virus Co-infections among Iranian High-Risk Groups: A Systematic Review and Meta- Analysis
Amir Almasi Hashiani ; Farzin Sadeghi ; Erfan Ayubi ; Shahab Rezaeian ; Yousef Moradi ; Kamyar Mansori ; Behzad Gholamaliei ; Abolfazl Mohammadbeigi ; Salman Khazaei
Malaysian Journal of Medical Sciences 2019;26(3):37-48
Co-infection with hepatitis B and C among HIV infected patients are prevalent among
high-risk populations. This meta-analysis aimed to estimate the prevalence of HIV, HCV and HBV
co-infections among high-risk populations in Iran.
We systematically searched the national and international electronic databases until 2016.
The primary outcome was the prevalence of HIV, HBV, HCV and HIV co-infections in different
high-risk populations in Iran. All English and Persian studies conducted on Iranian high-risk
groups were included in the study. The review was reported based on PRISMA guidelines and data
were analysed at 95% confidence level using random effect models.Overall, 916 relevant papers were recognised and 14 articles were included in the metaanalysis.
The pooled estimates of HBV/HCV, HCV/HIV, HBV/HIV and HBV/HCV/HIV were
1.3% (95%CI: 0.5–2.1), 16.3% (95%CI: 1.1–31.6), 0.5% (95%CI: 0–1.4) and 0.5% (95%CI: 0.2–0.8),
respectively. Based on subgroup analysis, there was a higher proportion of all co-infections from
the years 2010–2016 as compared to that of the years 2003–2009.
Our results highlighted that HCV/HIV co-infection in Iranian high-risk groups including
injection drug users (IDUs) and prisoners is common. In addition, the increasing trend of coinfections
should be considered alarming for policymakers.
2.Endovascular Therapy in the Extended Time Window for Large Vessel Occlusion in Patients With Pre-Stroke Disability
Kanta TANAKA ; Hiroshi YAMAGAMI ; Muhammad M. QURESHI ; Kazutaka UCHIDA ; James E. SIEGLER ; Raul G. NOGUEIRA ; Shinichi YOSHIMURA ; Nobuyuki SAKAI ; Nicolas MARTINEZ-MAJANDER ; Simon NAGEL ; Jelle DEMEESTERE ; Volker PUETZ ; Diogo C. HAUSSEN ; Mohamad ABDALKADER ; Marta OLIVE-GADEA ; Mahmoud H. MOHAMMADEN ; João Pedro MARTO ; Anne DUSART ; Simon WINZER ; Liisa TOMPPO ; Francois CAPARROS ; Hilde HENON ; Flavio BELLANTE ; João Nuno RAMOS ; Santiago ORTEGA-GUTIERREZ ; Sunil A. SHETH ; Stefania NANNONI ; Johannes KAESMACHER ; Lieselotte VANDEWALLE ; Sergio SALAZAR-MARIONI ; Mudassir FAROOQUI ; Pekka VIRTANEN ; Rita VENTURA ; Syed ZAIDI ; Alicia C. CASTONGUAY ; Ajit S. PURI ; Behzad FARZIN ; Hesham E. MASOUD ; Piers KLEIN ; Jessica JESSER ; Manuel REQUENA ; Tomas DOBROCKY ; Daniel P.O. KAISER ; Erno PELTOLA ; Davide STRAMBO ; Markus A. MÖHLENBRUCH ; Eugene LIN ; Peter A. RINGLEB ; Osama O. ZAIDAT ; Charlotte CORDONNIER ; Daniel ROY ; Robin LEMMENS ; Marc RIBO ; Daniel STRBIAN ; Urs FISCHER ; Patrik MICHEL ; Jean RAYMOND ; Thanh N. NGUYEN
Journal of Stroke 2024;26(2):269-279
Background:
and Purpose We compared the outcomes of endovascular therapy (EVT) in an extended time window in patients with large-vessel occlusion (LVO) between patients with and without pre-stroke disability.
Methods:
In this prespecified analysis of the multinational CT for Late Endovascular Reperfusion study (66 participating sites, 10 countries between 2014 and 2022), we analyzed data from patients with acute ischemic stroke with a pre-stroke modified Rankin Scale (mRS) score of 0–4 and LVO who underwent EVT 6–24 hours from the time last seen well. The primary outcome was the composite of functional independence (FI; mRS score 0–2) or return to the pre-stroke mRS score (return of Rankin, RoR) at 90 days. Outcomes were compared between patients with pre-stroke disability (pre-stroke mRS score 2–4) and those without (mRS score 0–1).
Results:
A total of 2,231 patients (median age, 72 years; median National Institutes of Health Stroke Scale score, 16) were included in the present analysis. Of these, 564 (25%) had pre-stroke disability. The primary outcome (FI or RoR) was observed in 30.7% of patients with pre-stroke disability (FI, 16.5%; RoR, 30.7%) compared to 44.1% of patients without (FI, 44.1%; RoR, 13.0%) (P<0.001). In multivariable logistic regression analysis with inverse probability of treatment weighting, pre-stroke disability was not associated with significantly lower odds of achieving FI or RoR (adjusted odds ratio 0.73, 95% confidence interval 0.43–1.25). Symptomatic intracranial hemorrhage occurred in 6.3% of both groups (P=0.995).
Conclusion
A considerable proportion of patients with late-presenting LVO and pre-stroke disability regained pre-stroke mRS scores after EVT. EVT may be appropriate for patients with pre-stroke disability presenting in the extended time window.